⌘K

Login Start Free

Home/Filings/4/0000711377-17-000023

4//SEC Filing

BRADLEY EDWARD 4

Accession 0000711377-17-000023

CIK 0000711377other

View on SEC.gov Company Profile

Filed

Sep 21, 8:00 PM ET

Accepted

Sep 22, 1:55 PM ET

Size

15.6 KB

Accession

0000711377-17-000023

Insider Transaction Report

Form 4

Period: 2017-09-20

NEOGEN CORPNEOG

Vice President

Transactions

Exercise/Conversion
Common Stock
2017-09-20$39.61/sh+11,400$451,554→ 95,112 total
Exercise/Conversion
Common Stock (Right to Buy)
2017-09-20−11,400→ 86,550 total
Exercise: $39.61Exp: 2019-10-31→ Common Stock (11,400 underlying)
Exercise/Conversion
Common Stock
2017-09-20$47.12/sh+5,276$248,605→ 81,274 total
Sale
Common Stock
2017-09-20$71.28/sh−38,876$2,771,128→ 61,512 total
Exercise/Conversion
Common Stock
2017-09-20$36.07/sh+22,200$800,681→ 83,712 total
Exercise/Conversion
Common Stock (Right to Buy)
2017-09-20−22,200→ 97,950 total
Exercise: $36.07Exp: 2018-08-30→ Common Stock (22,200 underlying)
Exercise/Conversion
Common Stock (Right to Buy)
2017-09-20−5,276→ 81,274 total
Exercise: $47.12Exp: 2020-11-08→ Common Stock (5,276 underlying)

Footnotes (3)

[F1]Options were granted August 30, 2013, have five year lives, and vest in equal annual 20% installments on each of the first five anniversary dates of the grant
[F2]Options were granted October 1, 2014, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant
[F3]Options were granted October 8, 2015, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

NEOGEN CORP

CIK 0000711377

Entity typeother

Related Parties

1

filerCIK 0001189021

Filing Metadata

Form type: 4
Filed: Sep 21, 8:00 PM ET
Accepted: Sep 22, 1:55 PM ET
Size: 15.6 KB

View on SEC.gov